InvestorsHub Logo
Followers 11
Posts 1237
Boards Moderated 0
Alias Born 03/03/2019

Re: None

Thursday, 01/21/2021 2:42:30 PM

Thursday, January 21, 2021 2:42:30 PM

Post# of 3191
Investigational use warning: “ANN ARBOR, Mich., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company, today announced it has entered into a development and supply agreement with Qorvo Biotechnologies, LLC (Qorvo), a wholly-owned subsidiary of Qorvo, Inc. (Nasdaq: QRVO) focused on bringing its piezo-electric Bulk Acoustic Wave (BAW) sensor to the veterinary health sector. Under the terms of this agreement, Zomedica has exclusive, global rights to develop and market Qorvo's investigational point-of-care diagnostic platform for veterinary use.”

https://www.qorvo.com/newsroom/news/2018/zomedica-signs-exclusive-agreement-with-qorvo-biotechnologies-for-global-vet-rights-to-point-of-care
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZOM News